paclitaxel has been researched along with Histiocytoma, Benign Fibrous in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gabbert, HE; Gerharz, CD; Reinecke, P; Schmitz, M; Steckstor, M | 1 |
Aravantinos, G; Bafaloukos, D; Dimopoulos, AM; Fountzilas, G; Gogas, H; Kalofonos, C; Kosmidis, P; Linardou, H; Papadimitriou, C; Papakostas, P; Skarlos, D | 1 |
Benjamin, R; Linke, KA; Moseley, SH; Papadopoulos, NE; Patel, SR; Plager, C; Spirindonidis, CH | 1 |
2 trial(s) available for paclitaxel and Histiocytoma, Benign Fibrous
Article | Year |
---|---|
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Female; Histiocytoma, Benign Fibrous; Humans; Leiomyosarcoma; Liposarcoma; Liposomes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Safety; Sarcoma; Survival Rate; Time Factors; Treatment Outcome | 2004 |
Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants.
Topics: Adult; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Chondrosarcoma; Female; Histiocytoma, Benign Fibrous; Humans; Male; Middle Aged; Osteosarcoma; Paclitaxel | 1996 |
1 other study(ies) available for paclitaxel and Histiocytoma, Benign Fibrous
Article | Year |
---|---|
Chemotherapeutic potential of plant alkaloids and multidrug resistance mechanisms in malignant fibrous histiocytoma of the heart.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Separation; Cell Survival; Cells, Cultured; Coloring Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Heart Neoplasms; Histiocytoma, Benign Fibrous; Humans; Inhibitory Concentration 50; Paclitaxel; Phenotype; Plant Extracts; Soft Tissue Neoplasms; Tetrazolium Salts; Thiazoles; Vault Ribonucleoprotein Particles; Vincristine | 2004 |